BioCentury
ARTICLE | Company News

Competitive Technologies Inc., Palatin genitourinary news

November 1, 2004 8:00 AM UTC

CTT demanded arbitration with PTN, claiming material breach of the terms of the partners' 1997 license agreement for the exclusive use of CTT's Erectide peptide hormone analog for erectile dysfunction...